Morphogens and growth factor signalling in the myeloma bone-lining niche
Multiple myeloma is a malignancy caused by the clonal expansion of abnormal plasma cells. Myeloma cells have proven to be incredibly successful at manipulating their microenvironment to promote growth and to evade modern therapies. They have evolved to utilise the integral signalling pathways of the...
Автори: | Morris, EV, Edwards, CM |
---|---|
Формат: | Journal article |
Мова: | English |
Опубліковано: |
Springer
2021
|
Схожі ресурси
Схожі ресурси
-
Transcriptomic profiling of the myeloma bone-lining niche reveals BMP signalling inhibition to improve bone disease
за авторством: Gooding, S, та інші
Опубліковано: (2019) -
Transcriptomic profiling of the myeloma bone-lining niche reveals BMP signalling inhibition to improve bone disease
за авторством: Sarah Gooding, та інші
Опубліковано: (2019-10-01) -
PB2082: BONE MORPHOGENIC PROTEIN-6 PROMOTES THE PROLIFERATION AND INHIBITS APOPTOSIS IN MULTIPLE MYELOMA
за авторством: Jiaqi Fu, та інші
Опубліковано: (2023-08-01) -
Myeloma and marrow adiposity: Unanswered questions and future directions
за авторством: Morris, EV, та інші
Опубліковано: (2021) -
The antidiabetic drug metformin acts on the bone microenvironment to promote myeloma cell adhesion to preosteoblasts and increase myeloma tumour burden in vivo
за авторством: Gámez, B, та інші
Опубліковано: (2021)